Regulation of Hfe by stress factors in BV-2 cells

被引:10
作者
Lee, SY [1 ]
Connor, JR [1 ]
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Neurosurg,GM Leader Family Lab Alzheimers Di, Hershey, PA 17033 USA
关键词
AD; beta-amyloid; Hfe; hydrogen peroxide; iron; serum stress;
D O I
10.1016/j.neurobiolaging.2004.08.006
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Mutations in the Hfe gene can be associated with the iron overload disorder known as hemochromatosis. A number of recent studies suggest that carrying an Hfe mutation is a risk factor or genetic modifier for Alzheimer's disease (AD). In AD, Hfe protein expression is induced on cells associated with neuritic plaques and on neurons in the periplaque area. In this study, the factors that may be responsible for induction of Hfe in AD brain were determined using BV-2 cells. We expression was induced by serum deprivation, menadione and beta-amyloid. The labile iron pool was consistently decreased when Hfe expression increased. However, the changes in expression of Hfe appeared independent of the expression of transferrin receptor and ferritin. These data provide insight into the induction of Hfe in AD and indicate that Hfe expression may be a protective function to limit cellular iron exposure during cell stress. These results are the first in a series of studies to understand how mutations in Hfe can be a risk factor for AD. (c) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:803 / 812
页数:10
相关论文
共 65 条
[1]   Clinical consequences of iron overload in hemochromatosis homozygotes [J].
Ajioka, RS ;
Kushner, JP .
BLOOD, 2003, 101 (09) :3351-3354
[2]   Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis [J].
Bastin, JM ;
Jones, M ;
O'Callaghan, CA ;
Schimanski, L ;
Mason, DY ;
Townsend, ARM .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) :931-941
[3]   The basal ganglia in haemochromatosis [J].
Berg, D ;
Hoggenmüller, U ;
Hofmann, E ;
Fischer, R ;
Kraus, M ;
Scheurlen, M ;
Becker, G .
NEURORADIOLOGY, 2000, 42 (01) :9-13
[4]   Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI [J].
Berlin, D ;
Chong, G ;
Chertkow, H ;
Bergman, H ;
Phillips, NA ;
Schipper, HA .
NEUROBIOLOGY OF AGING, 2004, 25 (04) :465-474
[5]   Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA [J].
Beutler, E ;
Felitti, VJ ;
Koziol, JA ;
Ho, NJ ;
Gelbart, T .
LANCET, 2002, 359 (9302) :211-218
[6]  
BIRGEGARD G, 1984, SCAND J HAEMATOL, V33, P43
[7]   Iron: A pathological mediator of Alzheimer disease? [J].
Bishop, GM ;
Robinson, SR ;
Liu, Q ;
Perry, G ;
Atwood, CS ;
Smith, MA .
DEVELOPMENTAL NEUROSCIENCE, 2002, 24 (2-3) :184-187
[8]  
BODOVITZ S, 1995, J NEUROCHEM, V64, P307
[9]   Genetics of haemochromatosis [J].
Bomford, A .
LANCET, 2002, 360 (9346) :1673-1681
[10]   Promotion of transition metal-induced reactive oxygen species formation by β-amyloid [J].
Bondy, SC ;
Guo-Ross, SX ;
Truong, AT .
BRAIN RESEARCH, 1998, 799 (01) :91-96